Combined targeting of LSD1 (KDM1A) and histone deacetylases exerts superior efficacy against human AML.
Warren Fiskus
No relevant relationships to disclose
Sunil Sharma
Employment or Leadership Position - Beta Cat Pharmaceuticals (U)
Stock Ownership - Beta Cat Pharmaceuticals
Research Funding - Beta Cat Pharmaceuticals
Rekha Rao
No relevant relationships to disclose
Ramesh Balusu
No relevant relationships to disclose
Sreedhar Venkannagari
No relevant relationships to disclose
Siddhartha Ganguly
No relevant relationships to disclose
David Bearss
Stock Ownership - Salarius Pharmaceuticals
Kapil N. Bhalla
Consultant or Advisory Role - Beta Cat Pharmaceuticals (U)
Research Funding - Novartis